| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pachman Matthew | VP, Chief Risk/Ethics Officer | 555 12TH STREET NW, WASHINGTON | By: Michael Rosenthall, Attorney-in-Fact For: Matthew Pachman | 12 Mar 2026 | 0001634237 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCN | Common Stock | Award | +153 | +9% | $0.000000* | 1,844 | 11 Mar 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Restricted stock units will vest, and the equivalent number of shares of common stock will be released, as follows: 50% on the first anniversary of the date of grant and 50% on the second anniversary of the date of grant. |